Use of glycoprotein IIb/IIIa receptor antagonist in prosthetic valve thrombosis

Author： Caceres-Loriga F. Santos-Gracia J.

ISSN： 1369-1635

Source： Platelets, Vol.21, Iss.7, 2010-11, pp. : 583-583

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Optimal Route of Administration of the Glycoprotein IIb/IIIa Receptor Antagonist Abciximab During Percutaneous Coronary Intervention; Intravenous Versus Intracoronary

Current Cardiology Reviews, Vol. 4, Iss. 4, 2008-11 ,pp. : 293-299

Bentham Science Publishers

Access to resources Recommend Favorite

BIOLOGICAL MATRIX-DEPENDENT PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS OF A NOVEL PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR ANTAGONIST, XU063, IN BEAGLE DOGS

By Kapil R.P. Emm T.A. Mousa S.A. Padovani P.K. Quon C.Y. Lam G.N.

Thrombosis Research, Vol. 86, Iss. 3, 1997-05 ,pp. : 221-232

Elsevier

Access to resources Recommend Favorite

Fibrinogen as a Factor of Thrombosis - GP IIb/IIIa as prototypic adhesion receptor

By Zoutremepuich F. Aguejouf O. Belougne-Malfatti E. Doutremepuich C.

Thrombosis Research, Vol. 90, Iss. 2, 1998-04 ,pp. : 57-64

Elsevier

Access to resources Recommend Favorite

Intravenous Administration of the Glycoprotein IIb-IIIa Receptor Antagonist 7E3 Induces Reperfusion of an Acute Thrombotic Occlusion of the Canine Coronary Artery - Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and ''clinical restenosis''

By Shetler T.J. Bailey B.D. Jakubowski J.A. Jackson C.V.

Thrombosis Research, Vol. 90, Iss. 2, 1998-04 ,pp. : 95-100

Elsevier

Access to resources Recommend Favorite

Structural Biology of Glycoprotein IIb-IIIa

By Bennett J.S.

Trends in Cardiovascular Medicine, Vol. 6, Iss. 1, 1996-01 ,pp. : 31-36

Elsevier

Access to resources Recommend Favorite